Brokerages Set Itron, Inc. (NASDAQ:ITRI) Price Target at $136.25

Itron, Inc. (NASDAQ:ITRI) has received a consensus rating of “Moderate Buy” from the eleven analysts that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $136.5455.

ITRI has been the topic of several analyst reports. Stephens set a $130.00 target price on shares of Itron in a research note on Monday, August 4th. TD Cowen upped their target price on shares of Itron from $139.00 to $145.00 and gave the company a “buy” rating in a report on Friday, June 20th. JPMorgan Chase & Co. raised shares of Itron from a “neutral” rating to an “overweight” rating and upped their target price for the company from $128.00 to $145.00 in a report on Thursday, July 31st. Johnson Rice cut shares of Itron from a “buy” rating to an “accumulate” rating in a report on Friday, August 1st. Finally, Guggenheim reaffirmed a “buy” rating and set a $155.00 target price (up from $133.00) on shares of Itron in a report on Monday, July 14th.

Insiders Place Their Bets

In other Itron news, SVP Christopher E. Ware sold 351 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $43,983.81. Following the completion of the transaction, the senior vice president directly owned 19,117 shares in the company, valued at $2,395,551.27. This represents a 1.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Joan S. Hooper sold 970 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $121,550.70. Following the completion of the transaction, the chief financial officer owned 88,394 shares of the company’s stock, valued at approximately $11,076,652.14. The trade was a 1.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,037 shares of company stock valued at $380,566. Insiders own 1.51% of the company’s stock.

Hedge Funds Weigh In On Itron

A number of hedge funds have recently modified their holdings of the company. Invesco Ltd. boosted its position in shares of Itron by 2.7% in the first quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company’s stock worth $242,076,000 after purchasing an additional 59,962 shares during the period. Geode Capital Management LLC boosted its position in shares of Itron by 2.0% in the second quarter. Geode Capital Management LLC now owns 1,109,851 shares of the scientific and technical instruments company’s stock worth $146,107,000 after purchasing an additional 21,925 shares during the period. Handelsbanken Fonder AB boosted its position in shares of Itron by 21.2% in the second quarter. Handelsbanken Fonder AB now owns 943,564 shares of the scientific and technical instruments company’s stock worth $124,201,000 after purchasing an additional 165,300 shares during the period. Amundi boosted its position in shares of Itron by 18.4% during the first quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company’s stock worth $97,313,000 after acquiring an additional 144,361 shares during the last quarter. Finally, First Trust Advisors LP boosted its position in shares of Itron by 2.6% during the second quarter. First Trust Advisors LP now owns 757,719 shares of the scientific and technical instruments company’s stock worth $99,739,000 after acquiring an additional 19,476 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors.

Itron Trading Down 0.3%

Shares of NASDAQ ITRI opened at $120.12 on Tuesday. The firm’s 50 day moving average price is $129.10 and its 200-day moving average price is $117.07. The company has a market cap of $5.49 billion, a PE ratio of 20.53, a P/E/G ratio of 0.66 and a beta of 1.46. Itron has a 52-week low of $90.11 and a 52-week high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04.

Itron (NASDAQ:ITRI) last issued its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.29. The firm had revenue of $606.76 million for the quarter, compared to the consensus estimate of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The business’s revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, equities research analysts expect that Itron will post 5.33 EPS for the current fiscal year.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.